Clinical Trial Update: Safety and Efficacy Study of Photopheresis Plus Standard Therapy to Treat Chronic Graft-versus-Host Disease [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of photopheresis plus standard therapy for chronic graft-versus-host disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Extracorporeal Photopheresis

Snippet

Sponsor: Mallinckrodt | Conditions: Graft-versus-Host Disease | Phase 2 | Status: COMPLETED